Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $838.10 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $235.76 | 10 | $0 (2024) |
| Lilly USA, LLC | $229.16 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.48 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $34.63 | 1 | $0 (2024) |
| Eisai Inc. | $30.43 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $29.24 | 1 | $0 (2024) |
| Ardelyx, Inc. | $27.86 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $24.72 | 1 | $0 (2024) |
| Medtronic, Inc. | $21.94 | 1 | $0 (2022) |
| Phadia US Inc. | $21.86 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $345.08 | 13 | Novo Nordisk Inc ($115.21) |
| 2023 | $288.22 | 15 | Lilly USA, LLC ($128.46) |
| 2022 | $159.81 | 8 | Novartis Pharmaceuticals Corporation ($104.92) |
| 2021 | $44.99 | 2 | Lilly USA, LLC ($26.58) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Allergy/Immunology | ||||||
| 06/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Biological | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.63 | General |
| 04/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Neurology | ||||||
| 02/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.77 | General |
| 05/23/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
| 05/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Diabetes | ||||||
| 03/08/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.86 | General |
| 02/02/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Obesity | ||||||
| 01/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 329 | 474 | $107,406 | $37,085 |
| 2020 | 3 | 608 | 824 | $181,946 | $62,404 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 177 | 182 | $58,058 | $20,113 | 34.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 152 | 292 | $49,348 | $16,972 | 34.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 267 | 272 | $86,768 | $30,116 | 34.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 314 | 525 | $88,725 | $30,080 | 33.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 27 | 27 | $6,453 | $2,208 | 34.2% |
About Kashan Singh
Kashan Singh is a Primary Care healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1235438490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kashan Singh has received a total of $838.10 in payments from pharmaceutical and medical device companies, with $345.08 received in 2024. These payments were reported across 38 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($838.10).
As a Medicare-enrolled provider, Singh has provided services to 937 Medicare beneficiaries, totaling 1,298 services with total Medicare billing of $99,489. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Staten Island, NY
- Active Since 03/26/2011
- Last Updated 12/06/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1235438490
Products in Payments
- MOUNJARO (Drug) $175.80
- Ozempic (Drug) $117.77
- LEQVIO (Drug) $104.16
- Wegovy (Drug) $40.00
- Leqembi (Drug) $30.43
- VOQUEZNA (Drug) $29.24
- IBSRELA (Drug) $27.86
- EMGALITY (Drug) $26.78
- TRULICITY (Drug) $26.58
- Veozah (Drug) $24.72
- Rybelsus (Drug) $22.40
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $21.94
- ImmunoCAP (Device) $21.86
- ENTRESTO (Drug) $21.32
- SHINGRIX (Biological) $21.11
- Saxenda (Drug) $19.96
- ZENPEP (Drug) $18.41
- TRUMENBA (Biological) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Staten Island
Edward Levine, Md, MD
Primary Care — Payments: $5,187
Kertje Rubenstein
Primary Care — Payments: $200.24
Joy Stennett
Primary Care — Payments: $183.10
Rosa Miller
Primary Care — Payments: $146.00
Pui Man Sit, Np, NP
Primary Care — Payments: $38.73
Diana Coseglia-Danna, Rn, Hnp, Fnp, RN, HNP, FNP
Primary Care